Of note, overexpression of SNCG has been associated with diseases to which obese individuals are more prone (e.g., esophageal, colorectal, prostate, and, in particular, breast cancer, but also some neurodegenerative disorders).[74] Considering this, along with the pioneering impact of exogenous SNCG on fat cells and circulating measures taken in obese and lean subjects, further investigations and assessment in additional cellular systems and clinical samples are warranted. Here, SNCG is linked to breast carcinoma.